# FDA Inspection 1046134 - Rentschler Biopharma Inc. - March 26, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-inc/b20fd2e8-f6c5-4b7f-b897-73d82dc0902f/
Source feed: FDA_Inspections

> FDA Inspection 1046134 for Rentschler Biopharma Inc. on March 26, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046134
- Company Name: Rentschler Biopharma Inc.
- Inspection Date: 2018-03-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1298478 - 2025-12-10](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-inc/9a33c509-4352-4da8-a638-1145baeb9d2f/)
- [FDA Inspection 1259307 - 2025-01-17](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-inc/b89bb7a4-2ab4-4f84-8b76-81b92852f722/)
- [FDA Inspection 1259307 - 2025-01-17](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-inc/fdfa31e1-e0c6-4326-a766-0c0d2116da07/)
- [FDA Inspection 1116307 - 2019-12-13](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-inc/a995a5c0-74f0-4822-8518-df814c6559fa/)
- [FDA Inspection 961189 - 2016-02-23](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-inc/633a7259-31f0-4259-8af5-b544f44d6abb/)

Company: https://www.globalkeysolutions.net/companies/rentschler-biopharma-inc/5ef7256a-aef2-44ce-a792-80c28829c138

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d